Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.09.11.675626

Learning genetic values of individuals with incomplete pedigree, genomic and phenotypic data

Abstract

Prediction of outcomes is important in personalized medicine, animal and plant breeding. Typical inputs for building prediction models in agriculture include genealogies, molecular markers and phenotypes. Information is seldom complete, i.e., there may be individuals that lack at least one of such inputs. For instance, all individuals may possess pedigree data but only a fraction is genotyped for molecular markers. A solution for such situation is known as "single-step best linear unbiased prediction" (SS-BLUP). A more general scenario is one where, in addition to the setting of SS-BLUP, there are subjects with genomic data but lacking genealogy, with or without phenotypes. Our study presents a novel "single-step" prediction method that accommodates a wider degree of incompleteness than SS-BLUP. It does not employ imputation or approximations and is based on basic Bayesian principles of combining distinct prior opinions. The proposed method, Hy-BLUP ("Hy" for "hybrid") uses a prior that combines knowledge from the population about variation derived from pedigree and from markers, as if these two sources of information were independent. Such assumption may over-state prior precision, but Bayesian theory dictates that it should be over-ridden as information from data accrues.The Bayesian logic defines the weights assigned to the sources implictly. However, additional weights (wAand wG for pedigree and genomic information, respectively) may be introduced as tuning parameters. From an inferential perspective, the weights and the variance components are not jointly identified in the likelihood function. However, given the variance components, some Bayesian learning about the weights can be obtained. The prior induces a precision matrix (inverse of the covariance matrix) automatically, without use of cumbersome matrix algebra arguments or approximations. The prior is combined with the data and, given the weights (if any) and variance parameters, the estimating "mixed model" equations can be built and computed directly. The method was evaluated using a publicly available data set consisting of 599 inbred lines of wheat genotyped for binary markers and with full pedigree information; the target trait was grain yield. The evaluation used several experiments that simulated various patterns of incompleteness and a training-testing layout supplemented by bootstrapping or random reconstruction of sets. There were minor differences between SS-BLUP and Hy-BLUP in predictive ability.The discussion includes a multiple-trait generalization of Hy-BLUP that may be useful in situations where some individuals are not phenotyped for some trait (e.g., animal carcass weight in a fully-pedigreed breeding nucleus) while others (not pedigreed) are genotyped, scored and destroyed for commercial or laboratory purposes. The study provides a proof-of-concept of the potential usefulness of Hy-BLUP for routine genome-enabled prediction in individuals with irregular patterns of information.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Gianola, D., Aguilar, I., Ravagnolo, O.. 2025-09-16. Learning genetic values of individuals with incomplete pedigree, genomic and phenotypic data. https://doi.org/10.1101/2025.09.11.675626

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Mechanism-selective deep mutational scanning distinguishes ERCC2 disease phenotypes

Pathogenic ERCC2 variants cause xeroderma pigmentosum (XP), trichothiodystrophy (TTD) or both, yet variant effect scores are usually interpreted only as measures of pathogenicity rather than of which disease mechanism is disrupted. XPD, the ERCC2-encoded TFIIH subunit, functions in both nucleotide excision repair and transcription. Using yeast complementation deep mutational scanning, we measured the effects of nearly all XPD amino acid substitutions. The assay was mechanism-selective: it preferentially reported transcription-associated function, with pronounced intolerance at the p44 interface, whereas many substitutions affecting DNA binding and helicase activity retained near-wild-type fitness. Accordingly, TTD variants had much lower fitness than XP variants. Computational predictors discriminated pathogenic from benign variants similarly across phenotypes, but the DMS distinguished XP from TTD variants better than all 73 predictors tested. Phenotype-specific ACMG/AMP calibration provided evidence in both directions for TTD but mainly pathogenic evidence for XP. Thus, the selectivity of functional assays, often viewed as a limitation, can reveal disease mechanisms and support phenotype-aware variant interpretation.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗